Showing articles whose micro-themes are very close to:
#Ebola vaccine EPAR
- No closely related articles found yet.
- Ervebo vaccine: EMA EPAR summary for EU authorization (ema.europa.eu) | 14d ago
- FDA Expands ERVEBO Approval to Children Aged 12 Months and Older (merck.com) | 14d ago
- Coalition for Epidemic Preparedness Innovations (CEPI) updates Ebola vaccine development progress (youtube.com) | 14d ago
- ERVEBO (Ebola Zaire Vaccine, Live) – Prescribing Information (merck.com) | 69d ago
- ERVEBO Vaccine: FDA Approval Page (fda.gov) | 14d ago
- CDC Publishes ERVEBO Ebola Vaccine Product Information for Healthcare Providers (cdc.gov) | 14d ago
- WHO Chief Tedros Briefs Media on Ebola Vaccine Options in DRC (youtube.com) | 17d ago
- FDA-Approved Ebola Treatment Ebanga (fda.gov) | 17d ago
- FDA approves Ebanga (ansuvimab-zykl) for Zaire ebolavirus treatment (fda.gov) | 14d ago
- WHO Issues Updated Guideline on Therapeutics for Ebola Virus Disease (iris.who.int) | 14d ago
- Ring Vaccination with rVSV-ZEBOV-GP Significantly Reduces Ebola Incidence (2minutemedicine.com) | 17d ago
- Clinical Development of Ebola Vaccines (pmc.ncbi.nlm.nih.gov) | 17d ago
- WHO Technical Advisory Group recommends BDBV-specific vaccines as preferred, considers Ervebo for post-exposure use in Bundibugyo outbreak (iris.who.int) | 15d ago
- WHO selects vaccines, therapeutics for field trials against Ebola Bundibugyo outbreak in DRC (bioworld.com) | 11d ago
- WHO emergency guidance on licensed Ebola vaccine use during Bundibugyo virus disease outbreaks (who.int) | 12d ago
- WHO advises against routine use of Ervebo vaccine for Bundibugyo virus outbreak, recommends research rather than programmatic deployment (iris.who.int) | 12d ago
- WHO: Bundibugyo Ebola vaccine months away from human trials (nbcnews.com) | 20d ago
- Ervebo Vaccine: Efficacy and Deployment Against Zaire Ebolavirus (youtube.com) | 14d ago
- Evidence to Recommendations for rVSVΔG-ZEBOV-GP Ebola Vaccine (cdc.gov) | 17d ago
- Brief review of Ebola virus disease and the One Health approach (pmc.ncbi.nlm.nih.gov) | 15d ago
- WHO Advisory Group Recommends Maftivimab for Clinical Trials in Bundibugyo Ebola Outbreak (rttnews.com) | 11d ago
- WHO considers experimental vaccines as Ebola cases exceed 500 in DRC (theguardian.com) | 15d ago
- Vaccine and antiviral R&D underway for rare Bundibugyo Ebola outbreak (bioworld.com) | 14d ago
- Search Begins for Vaccine as Bundibugyo Ebola Deaths Rise (pharmaphorum.com) | 19d ago
- Gavi allocates $50 million to Bundibugyo ebolavirus vaccine development and outbreak response (gavi.org) | 11d ago
- Ebola Virus Disease Vaccines – WHO Q&A (who.int) | 17d ago
- Ebola vaccines: Overview of Ervebo, Zabdeno, and Mvabea (en.wikipedia.org) | 14d ago
- Africa CDC: No Approved Vaccine for Ebola-Sudan Strain, Trial Underway (facebook.com) | 17d ago
- Ervebo Vaccine Protects Only Against Zaire ebolavirus, Not Bundibugyo Virus (nationalacademies.org) | 18d ago
- Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114 (pmc.ncbi.nlm.nih.gov) | 17d ago
- USAID OIG Report on International Ebola Response and Preparedness Data (oig.usaid.gov) | 15d ago
- Gavi statement on the Ebola disease outbreak in Democratic Republic of the Congo and Uganda (gavi.org) | 18d ago
Showing page 1 of 1
(32 total results)
← Prev
Next →